{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:29:12Z","timestamp":1790152152743,"version":"4.0.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2008,7,26]],"date-time":"2008-07-26T00:00:00Z","timestamp":1217030400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1007\/s00246-008-9267-3","type":"journal-article","created":{"date-parts":[[2008,7,25]],"date-time":"2008-07-25T13:58:15Z","timestamp":1216994295000},"page":"1033-1042","source":"Crossref","is-referenced-by-count":55,"title":["Cardiac Remodeling After Enzyme Replacement Therapy with Acid \u03b1-Glucosidase for Infants with Pompe Disease"],"prefix":"10.1007","volume":"29","author":[{"given":"Jami C.","family":"Levine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya S.","family":"Kishnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. T.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Rene","family":"Herlong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,7,26]]},"reference":[{"key":"9267_CR1","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.jpeds.2004.01.053","volume":"144","author":"P Kishnani","year":"2004","unstructured":"Kishnani P, Howell RR (2004) Pompe disease in infants and children. J Pediatrics 144:S35\u2013S43","journal-title":"J Pediatrics"},{"key":"9267_CR2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF02889850","volume":"45","author":"JL Griffin","year":"1984","unstructured":"Griffin JL (1984) Infantile acid maltase deficiency: muscle fiber hypertrophy and the ultrastructure of end-stage fibers. Virchows Arch Cell Pathol 45:37\u201350","journal-title":"Virchows Arch Cell Pathol"},{"key":"9267_CR3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/(SICI)1096-8628(19980827)79:1<69::AID-AJMG16>3.0.CO;2-K","volume":"79","author":"F Martiniuk","year":"1998","unstructured":"Martiniuk F, Chen A, Mack A et al (1998) Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease. Am J Med Gen 79:69\u201372","journal-title":"Am J Med Gen"},{"key":"9267_CR4","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1542\/peds.112.2.332","volume":"112","author":"HM Hout Van den","year":"2003","unstructured":"Van den Hout HM, Hop W, van Diggelen OP et al (2003) The natural course of infantile Pompe disease: 20 original cases compared with 133 cases from literature. Pediatrics 112:332\u2013340","journal-title":"Pediatrics"},{"key":"9267_CR5","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jpeds.2005.11.033","volume":"148","author":"PS Kishnani","year":"2006","unstructured":"Kishnani PS, Hwu WL, Mandel H et al (2006) A retrospective multinational multicenter study on the natural history of infantile-onset Pompe disease. J Pediatr 148:671\u2013676","journal-title":"J Pediatr"},{"key":"9267_CR6","first-page":"132","volume":"3","author":"A Amalfitano","year":"2001","unstructured":"Amalfitano A, Bengur AR, Morse RP et al (2001) Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I\/II clinical trial. Genet Med 3:132\u2013138","journal-title":"Genet Med"},{"key":"9267_CR7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(00)02533-2","volume":"356","author":"H Hout Van den","year":"2000","unstructured":"Van den Hout H, Reuser AJ, Vulto AG et al (2000) Recombinant human \u03b1-glucosidase 17 from rabbit milk in Pompe patients. Lancet 356:397\u2013398","journal-title":"Lancet"},{"key":"9267_CR8","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1542\/peds.113.5.e448","volume":"113","author":"JMP Hout Van den","year":"2004","unstructured":"Van den Hout JMP, Kamphoven JHJ, Winkel LPF et al (2004) Long-term intravenous treatment of Pompe disease with recombinant human \u03b1-glucosidase from milk. Pediatrics 113:e448\u2013e457","journal-title":"Pediatrics"},{"key":"9267_CR9","first-page":"259A","volume":"53","author":"P Kishnani","year":"2003","unstructured":"Kishnani P, Voit T, Nicolino M et al (2003) Enzyme replacement therapy with recombinant human \u03b1-glucosidase (rhGAA) in infantile Pompe disease: results form a phase 2 study. Pediatr Res 53:259A","journal-title":"Pediatr Res"},{"key":"9267_CR10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.nmd.2004.10.009","volume":"15","author":"L Klinge","year":"2005","unstructured":"Klinge L, Straub V, Neudorf U et al (2005) Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial. Neuromuscular Dis 15:24\u201331","journal-title":"Neuromuscular Dis"},{"key":"9267_CR11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jpeds.2006.02.035","volume":"149","author":"P Kishnani","year":"2006","unstructured":"Kishnani P, Nicolino M, Voit T et al (2006) Chinese hamster ovary cell-derived recombinant human acid alpha-glucosidease in infantile-onset Pompe disease. J Pediatr 149:89\u201397","journal-title":"J Pediatr"},{"key":"9267_CR12","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1152\/japplphysiol.01144.2004","volume":"99","author":"T Sluysman","year":"2005","unstructured":"Sluysman T, Colan SD (2005) Theoretical and empirical derivation of cardiovascular allometric relationships in children. J Appl Physiol 99:445\u2013457","journal-title":"J Appl Physiol"},{"key":"9267_CR13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.gim.0000195896.04069.5f","volume":"8","author":"AK Ansong","year":"2006","unstructured":"Ansong AK, Li JS, Ing R et al (2006) Electrocardiographic changes in Pompe disease following enzyme replacement therapy for Pompe disease. Genet Med 8:297\u2013301","journal-title":"Genet Med"},{"key":"9267_CR14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF02265613","volume":"2","author":"S Bharati","year":"1982","unstructured":"Bharati S, Serratto M, DuBrow I et al (1982) The conduction system in Pompe\u2019s disease. Pediatr Cardiol 2:25\u201332","journal-title":"Pediatr Cardiol"},{"key":"9267_CR15","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM200303203481224","volume":"348","author":"S Waldek","year":"2003","unstructured":"Waldek S (2003) PR interval and the response to enzyme-replacement therapy for Fabry\u2019s disease. N Engl J Med 348:1186\u20131187","journal-title":"N Engl J Med"},{"key":"9267_CR16","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1590\/S0066-782X1999001100004","volume":"73","author":"JL Jacob","year":"1999","unstructured":"Jacob JL, Leandro RL, Parro Junior A (1999) Pompe\u2019s disease or type IIa glycogenosis. Arq Bras Cardiol 73:435\u2013440","journal-title":"Arq Bras Cardiol"},{"key":"9267_CR17","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1525-0016(02)90716-1","volume":"6","author":"N Raben","year":"2002","unstructured":"Raben N, Jatkar T, Lee A et al (2002) Glycogen stored in skeletal but not in cardiac muscle in acid alpha-glucosidase mutant (Pompe) mice is highly resistant to transgene-encoded human enzyme. Mol Ther 6:601\u2013608","journal-title":"Mol Ther"},{"key":"9267_CR18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ymgme.2003.08.022","volume":"80","author":"N Raben","year":"2003","unstructured":"Raben N, Danon M, Gilbert AL et al (2003) Enzyme replacement therapy in the mouse model of Pompe disease. Mol Genet Metab 80:159\u2013169","journal-title":"Mol Genet Metab"},{"key":"9267_CR19","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1460-9592.2004.01242.x","volume":"14","author":"RJ Ing","year":"2004","unstructured":"Ing RJ, Cook DR, Bengur RA et al (2004) Anaesthetic management of infants with glycogen storage disease type II: a physiological approach. Paediatr Anaesth 14:514\u2013519","journal-title":"Paediatr Anaesth"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-008-9267-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00246-008-9267-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-008-9267-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T10:11:54Z","timestamp":1558692714000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00246-008-9267-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,26]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["9267"],"URL":"https:\/\/doi.org\/10.1007\/s00246-008-9267-3","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,26]]}}}